Processa Pharmaceuticals, Inc. Money Market Funds, at Carrying Value
Processa Pharmaceuticals, Inc. (PCSA) had Money Market Funds, at Carrying Value of $1.33 million as of 2018-12-31, per its 10-K/A filed 2019-04-08.
Discontinued › Notes › Cash and Cash Equivalents › Cash Equivalents, at Carrying Value
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2019-04-08
- 2018-12-31: Money Market Funds, at Carrying Value $1.33M.
- 2018-03-31: Money Market Funds, at Carrying Value $961.19K.
- 2017-12-31: Money Market Funds, at Carrying Value $1.30M.
- 2016-12-31: Money Market Funds, at Carrying Value $0.00.
| Period end | Money Market Funds, at Carrying Value |
|---|---|
| 2018-12-31 | $1.33M 10-K/A · filed 2019-04-08 |
| 2018-03-31 | $961.19K 10-Q · filed 2018-05-21 |
| 2017-12-31 | $1.30M 10-K/A · filed 2019-04-08 |
| 2016-12-31 | $0.00 10-K · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |